TY - JOUR AU - Danaei, G. AU - Ding, E. L. AU - Mozaffarian, D. PY - 2009 DA - 2009// TI - The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000058 DO - 10.1371/journal.pmed.1000058 ID - Danaei2009 ER - TY - JOUR AU - Pereira, M. AU - Lunet, N. AU - Azevedo, A. AU - Barros, H. PY - 2009 DA - 2009// TI - Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries JO - J Hypertens VL - 27 UR - https://doi.org/10.1097/HJH.0b013e3283282f65 DO - 10.1097/HJH.0b013e3283282f65 ID - Pereira2009 ER - TY - JOUR AU - Lloyd-Sherlock, P. AU - Beard, J. AU - Minicuci, N. AU - Ebrahim, S. AU - Chatterji, S. PY - 2014 DA - 2014// TI - Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control JO - Int J Epidemiol VL - 43 UR - https://doi.org/10.1093/ije/dyt215 DO - 10.1093/ije/dyt215 ID - Lloyd-Sherlock2014 ER - TY - JOUR AU - Ibrahim, M. M. AU - Damasceno, A. PY - 2012 DA - 2012// TI - Hypertension in developing countries JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)60861-7 DO - 10.1016/S0140-6736(12)60861-7 ID - Ibrahim2012 ER - TY - STD TI - Yoon SS, Fryar CD, Carroll MD. Hypertension prevalence and control among adults: United states, 2011-2014. NCHS data brief, no 220. https://www.cdc.gov/nchs/products/databriefs/db220.htm. Accessed 29 Jan 2018. UR - https://www.cdc.gov/nchs/products/databriefs/db220.htm ID - ref5 ER - TY - JOUR AU - Jha, V. AU - Garcia-Garcia, G. AU - Iseki, K. PY - 2013 DA - 2013// TI - Chronic kidney disease: global dimension and perspectives JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60687-X DO - 10.1016/S0140-6736(13)60687-X ID - Jha2013 ER - TY - JOUR AU - Iadecola, C. AU - Davisson, R. L. PY - 2008 DA - 2008// TI - Hypertension and cerebrovascular dysfunction JO - Cell Metabol VL - 7 UR - https://doi.org/10.1016/j.cmet.2008.03.010 DO - 10.1016/j.cmet.2008.03.010 ID - Iadecola2008 ER - TY - JOUR AU - Chow, C. K. AU - Teo, K. K. AU - Rangarajan, S. PY - 2013 DA - 2013// TI - Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries JO - JAMA VL - 310 UR - https://doi.org/10.1001/jama.2013.184182 DO - 10.1001/jama.2013.184182 ID - Chow2013 ER - TY - JOUR AU - Mills, K. T. AU - Bundy, J. D. AU - Kelly, T. N. PY - 2016 DA - 2016// TI - Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries JO - Circulation VL - 134 UR - https://doi.org/10.1161/CIRCULATIONAHA.115.018912 DO - 10.1161/CIRCULATIONAHA.115.018912 ID - Mills2016 ER - TY - JOUR AU - Yang, S. AU - Khang, Y. H. AU - Harper, S. PY - 2010 DA - 2010// TI - Understanding the rapid increase in life expectancy in South Korea JO - Am J Public Health VL - 100 UR - https://doi.org/10.2105/AJPH.2009.160341 DO - 10.2105/AJPH.2009.160341 ID - Yang2010 ER - TY - JOUR AU - Kim, K. I. AU - Kim, Y. AU - Kim, H. J. PY - 2008 DA - 2008// TI - Current status and characteristics of hypertension treatment by primary physicians in Korea: data from Korean epidemiology study on hypertension (KEY study) JO - Am J Hypertens VL - 21 UR - https://doi.org/10.1038/ajh.2008.191 DO - 10.1038/ajh.2008.191 ID - Kim2008 ER - TY - JOUR AU - Shin, J. AU - Park, J. B. AU - Kim, K. I. PY - 2015 DA - 2015// TI - 2013 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology and diagnosis of hypertension JO - Clin Hypertens VL - 21 UR - https://doi.org/10.1186/s40885-014-0012-3 DO - 10.1186/s40885-014-0012-3 ID - Shin2015 ER - TY - STD TI - Ministry of Health and Welfare (MOHW). Korean National Health and Nutrition Examination Survey (KNHANES). [Trends in the prevalence of hypertension in the population aged 30 above]. http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_11702_N105&conn_path=I. Accessed 29 Jan 2018. UR - http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_11702_N105&conn_path=I ID - ref13 ER - TY - JOUR AU - Shin, J. AU - Park, J. B. AU - Kim, K. I. PY - 2015 DA - 2015// TI - 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertension JO - Clin Hypertens VL - 21 UR - https://doi.org/10.1186/s40885-014-0013-2 DO - 10.1186/s40885-014-0013-2 ID - Shin2015 ER - TY - JOUR AU - Caldeira, D. AU - David, C. AU - Sampaio, C. PY - 2012 DA - 2012// TI - Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors JO - Am J Cardiovasc Drugs VL - 12 UR - https://doi.org/10.1007/BF03261835 DO - 10.1007/BF03261835 ID - Caldeira2012 ER - TY - JOUR AU - Bakris, G. L. AU - Sica, D. AU - Weber, M. PY - 2011 DA - 2011// TI - The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure JO - J Clin Hypertens VL - 13 UR - https://doi.org/10.1111/j.1751-7176.2010.00425.x DO - 10.1111/j.1751-7176.2010.00425.x ID - Bakris2011 ER - TY - JOUR AU - Harrell, R. E. AU - Karim, A. AU - Zhang, W. AU - Dudkowski, C. PY - 2016 DA - 2016// TI - Effects of age, sex, and race on the safety and pharmacokinetics of single and multiple doses of azilsartan medoxomil in healthy subjects JO - Clin Pharmacokinet VL - 55 UR - https://doi.org/10.1007/s40262-015-0333-8 DO - 10.1007/s40262-015-0333-8 ID - Harrell2016 ER - TY - STD TI - Edarbi (Azilsartan Medoxomil) Tablets. Summary of product characteristics. Takeda Pharma A/S; Taatstrup, Denmark. November 2016. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002293/human_med_001512.jsp&mid=WC0b01ac058001d124. Accessed 29 Jan 2018. UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002293/human_med_001512.jsp&mid=WC0b01ac058001d124 ID - ref18 ER - TY - STD TI - Edarbi (Azilsartan Medoxomil). Package insert. Takeda Pharmaceuticals America, Inc; Deerfield, IL. 2011. https://www.edarbi.com/media/pdf/EDARBI-PI.pdf. Accessed 29 Jan 2018. UR - https://www.edarbi.com/media/pdf/EDARBI-PI.pdf ID - ref19 ER - TY - JOUR AU - Handley, A. AU - Lloyd, E. AU - Roberts, A. AU - Barger, B. PY - 2016 DA - 2016// TI - Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study JO - Clin Experim Hypertens VL - 38 UR - https://doi.org/10.3109/10641963.2015.1081213 DO - 10.3109/10641963.2015.1081213 ID - Handley2016 ER - TY - JOUR AU - White, W. B. AU - Weber, M. A. AU - Sica, D. PY - 2011 DA - 2011// TI - Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension JO - Hypertension VL - 57 UR - https://doi.org/10.1161/HYPERTENSIONAHA.110.163402 DO - 10.1161/HYPERTENSIONAHA.110.163402 ID - White2011 ER - TY - JOUR AU - Sica, D. AU - White, W. B. AU - Weber, M. A. AU - Bakris, G. L. AU - Perez, A. AU - Cao, C. AU - Handley, A. AU - Kupfer, S. PY - 2011 DA - 2011// TI - Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring JO - J Clin Hypertens (Greenwich) VL - 13 UR - https://doi.org/10.1111/j.1751-7176.2011.00482.x DO - 10.1111/j.1751-7176.2011.00482.x ID - Sica2011 ER - TY - JOUR AU - Kassler-Taub, K. AU - Littlejohn, T. AU - Elliott, W. AU - Ruddy, T. AU - Adler, E. PY - 1998 DA - 1998// TI - Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan, in mild-to-moderate hypertension JO - Am J Hypertens VL - 11 UR - https://doi.org/10.1016/S0895-7061(97)00491-3 DO - 10.1016/S0895-7061(97)00491-3 ID - Kassler-Taub1998 ER - TY - JOUR AU - Hedner, T. AU - Oparil, S. AU - Rasmussen, K. AU - Rapelli, A. AU - Gatlin, M. AU - Kobi, P. AU - Sullivan, J. AU - Oddou-Stock, P. PY - 1999 DA - 1999// TI - A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension JO - Am J Hypertens VL - 12 UR - https://doi.org/10.1016/S0895-7061(99)00082-5 DO - 10.1016/S0895-7061(99)00082-5 ID - Hedner1999 ER - TY - JOUR AU - Brunner, H. R. PY - 2002 DA - 2002// TI - The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview JO - J Hum Hypertens VL - 16 UR - https://doi.org/10.1038/sj.jhh.1001391 DO - 10.1038/sj.jhh.1001391 ID - Brunner2002 ER - TY - JOUR AU - Campbell, P. AU - Ghuman, N. AU - Wakefield, D. AU - Wolfson, L. AU - White, W. B. PY - 2010 DA - 2010// TI - Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly JO - J Hum Hypertens VL - 24 UR - https://doi.org/10.1038/jhh.2010.8 DO - 10.1038/jhh.2010.8 ID - Campbell2010 ER - TY - JOUR AU - Vollmer, W. M. AU - Appel, L. J. AU - Svetkey, L. P. PY - 2005 DA - 2005// TI - Comparing office-based and ambulatory blood pressure monitoring in clinical trials JO - J Hum Hypertens VL - 19 UR - https://doi.org/10.1038/sj.jhh.1001772 DO - 10.1038/sj.jhh.1001772 ID - Vollmer2005 ER - TY - JOUR AU - Mancia, G. AU - Omboni, S. AU - Parati, G. AU - Ravogli, A. AU - Villani, A. AU - Zanchetti, A. PY - 1995 DA - 1995// TI - Lack of placebo effect on ambulatory blood pressure JO - Am J Hypertens VL - 8 UR - https://doi.org/10.1016/0895-7061(94)00250-F DO - 10.1016/0895-7061(94)00250-F ID - Mancia1995 ER - TY - JOUR AU - Staessen, J. A. AU - Thijs, L. AU - Clement, D. PY - 1994 DA - 1994// TI - Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension JO - J Hypertens VL - 12 ID - Staessen1994 ER - TY - JOUR AU - White, W. B. AU - Gulati, V. PY - 2015 DA - 2015// TI - Managing hypertension with ambulatory blood pressure monitoring JO - Curr Cardiol Rep VL - 17 UR - https://doi.org/10.1007/s11886-014-0556-6 DO - 10.1007/s11886-014-0556-6 ID - White2015 ER - TY - JOUR AU - Preston, R. A. AU - Materson, B. J. AU - Reda, D. J. AU - Williams, D. W. PY - 2000 DA - 2000// TI - Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study JO - JAMA Intern Med VL - 160 UR - https://doi.org/10.1001/archinte.160.10.1449 DO - 10.1001/archinte.160.10.1449 ID - Preston2000 ER - TY - JOUR AU - Bakris, G. L. AU - Lindholm, L. H. AU - Black, H. R. PY - 2010 DA - 2010// TI - Divergent results using clinic and ambulatory blood pressures report of a darusentan-resistant hypertension trial JO - Hypertension VL - 56 UR - https://doi.org/10.1161/HYPERTENSIONAHA.110.156976 DO - 10.1161/HYPERTENSIONAHA.110.156976 ID - Bakris2010 ER - TY - JOUR AU - Khan, J. M. AU - Beevers, D. G. PY - 2005 DA - 2005// TI - Management of hypertension in ethnic minorities JO - Heart VL - 91 UR - https://doi.org/10.1136/hrt.2004.044560 DO - 10.1136/hrt.2004.044560 ID - Khan2005 ER - TY - JOUR AU - Angeli, F. AU - Reboldi, G. AU - Verdecchia, P. PY - 2015 DA - 2015// TI - The 2014 hypertension guidelines: implications for patients and practitioners in Asia JO - Heart Asia VL - 7 UR - https://doi.org/10.1136/heartasia-2015-010639 DO - 10.1136/heartasia-2015-010639 ID - Angeli2015 ER - TY - JOUR AU - Hong, B. K. AU - Park, C. G. AU - Kim, K. S. PY - 2012 DA - 2012// TI - Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan JO - Am J Card Drugs VL - 12 UR - https://doi.org/10.2165/11597410-000000000-00000 DO - 10.2165/11597410-000000000-00000 ID - Hong2012 ER - TY - JOUR AU - Lee, S. E. AU - Kim, Y. J. AU - Lee, H. Y. PY - 2012 DA - 2012// TI - Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension JO - Clin Ther VL - 34 UR - https://doi.org/10.1016/j.clinthera.2012.01.024 DO - 10.1016/j.clinthera.2012.01.024 ID - Lee2012 ER - TY - JOUR AU - Youn, J. C. AU - Ihm, S. H. AU - Bae, J. H. PY - 2014 DA - 2014// TI - Efficacy and safety of 30-mg fimasartan for the treatment of patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, phase III clinical study JO - Clin Ther VL - 36 UR - https://doi.org/10.1016/j.clinthera.2014.07.004 DO - 10.1016/j.clinthera.2014.07.004 ID - Youn2014 ER - TY - JOUR AU - Makani, H. AU - Bangalore, S. AU - Supariwala, A. AU - Romero, J. AU - Argulian, E. AU - Messerli, F. H. PY - 2013 DA - 2013// TI - Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis JO - Eur Heart J VL - 35 UR - https://doi.org/10.1093/eurheartj/eht333 DO - 10.1093/eurheartj/eht333 ID - Makani2013 ER -